These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11030493)

  • 41. [Antiepileptic therapy with valproinic acid. Correlations of side effects and serum levels of valproinic acid].
    Fröscher W; Schulz HU; Gugler R
    Fortschr Med; 1979 Sep; 97(34):1464-6. PubMed ID: 159246
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Valproic acid for agitation in dementia.
    Lonergan ET; Cameron M; Luxenberg J
    Cochrane Database Syst Rev; 2004; (2):CD003945. PubMed ID: 15106227
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hematological effects of valproate in psychiatric patients: what are the risk factors?
    Vasudev K; Keown P; Gibb I; McAllister-Williams RH
    J Clin Psychopharmacol; 2010 Jun; 30(3):282-5. PubMed ID: 20473063
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Valproic acid and thrombocytopenia.
    Morris N; Barr RD; Pai KR; Kelton JG
    Can Med Assoc J; 1981 Jul; 125(1):63-4. PubMed ID: 6790153
    [No Abstract]   [Full Text] [Related]  

  • 45. Efficacy of and possible differences in tolerance to L-dopa tablets with different rates of release of the active substance.
    Völler GW; Muschard F
    Acta Neurol Scand; 1974; 50(3):391-3. PubMed ID: 4525037
    [No Abstract]   [Full Text] [Related]  

  • 46. Severe, isolated thrombocytopenia under polytherapy with carbamazepine and valproate.
    Finsterer J; Pelzl G; Hess B
    Psychiatry Clin Neurosci; 2001 Aug; 55(4):423-6. PubMed ID: 11442896
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sodium valproate and thrombocytopenia.
    Hoffman LM
    Can Med Assoc J; 1982 Feb; 126(4):358-9. PubMed ID: 6802479
    [No Abstract]   [Full Text] [Related]  

  • 48. A placebo-controlled trial of valproate in tardive dyskinesia.
    Nasrallah HA; Dunner FJ; McCalley-Whitters M
    Biol Psychiatry; 1985 Feb; 20(2):205-8. PubMed ID: 3918588
    [No Abstract]   [Full Text] [Related]  

  • 49. Absolute bioavailability and absorption characteristics of divalproex sodium extended-release tablets in healthy volunteers.
    Dutta S; Reed RC; Cavanaugh JH
    J Clin Pharmacol; 2004 Jul; 44(7):737-42. PubMed ID: 15199078
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacokinetics and safety of extended-release divalproex sodium tablets: morning versus evening administration.
    Dutta S; Reed RC; Cavanaugh JH
    Am J Health Syst Pharm; 2004 Nov; 61(21):2280-3. PubMed ID: 15552635
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transient thrombocytopenia in a child on sodium valproate.
    Cole AP
    Dev Med Child Neurol; 1978 Aug; 20(4):487-90. PubMed ID: 357235
    [No Abstract]   [Full Text] [Related]  

  • 52. [Thrombocyte values in adults during the treatment with DPA (Ergenyl)].
    Krause KH
    Med Welt; 1977 Jun; 28(24):1098-9. PubMed ID: 331015
    [No Abstract]   [Full Text] [Related]  

  • 53. Thrombocytopenia secondary to high valproate levels in children with epilepsy.
    Delgado MR; Riela AR; Mills J; Browne R; Roach ES
    J Child Neurol; 1994 Jul; 9(3):311-4. PubMed ID: 7930412
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sodium valproate in the treatment of resistant epilepsy.
    Hassan MN; Laljee HC; Parsonage MJ
    Acta Neurol Scand; 1976 Sep; 54(3):209-218. PubMed ID: 822682
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A double-blind, multiple-dose, placebo-controlled, cross-over study to compare the incidence of gastrointestinal complaints in healthy subjects given Doryx R and Vibramycin R.
    Berger RS
    J Clin Pharmacol; 1988 Apr; 28(4):367-70. PubMed ID: 3392234
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Delayed thrombocytopenia after valproic acid overdose.
    Lin WC; Tsao JH; Tsai SJ
    Gen Hosp Psychiatry; 2008; 30(5):489-90. PubMed ID: 18774438
    [No Abstract]   [Full Text] [Related]  

  • 57. Divalproex sodium in headache: literature review and clinical guidelines.
    Silberstein SD
    Headache; 1996 Oct; 36(9):547-55. PubMed ID: 8916563
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Valproic acid-induced thrombocytopenia may cause wound nonhealing in individuals with schizophrenia.
    Tseng YT; Ho PS; Wang CF; Liang CS
    Psychosomatics; 2015; 56(4):410-3. PubMed ID: 25016351
    [No Abstract]   [Full Text] [Related]  

  • 59. [Sodium valproate, platelet dysfunction and bleeding (author's transl)].
    Loiseau P
    Nouv Presse Med; 1981 Dec; 10(46):3789-90. PubMed ID: 6798554
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Valproic Acid-related anticonvulsant hypersensitivity syndrome and subsequent olanzapine-related neutropenia and thrombocytopenia: a case report.
    Lin YH; Chien YL
    J Clin Psychopharmacol; 2012 Feb; 32(1):132-3. PubMed ID: 22217947
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.